Reply: The role and limitations of CAM use in children and adolescents with cancer: let's take a look beyond prevalence rate

Affiliations

¹ Division of Pediatric Hematology/Oncology/Stem Cell Transplant, Columbia University Medical Center; Institute of Human Nutrition, Columbia University Medical Center.

Comment

Elena J Ladas et al. Pediatr Blood Cancer. 2014 Nov.

. 2014 Nov;61(11):2124.

doi: 10.1002/pbc.25180. Epub 2014 Aug 22.

¹ Division of Pediatric Hematology/Oncology/Stem Cell Transplant, Columbia University Medical Center; Institute of Human Nutrition, Columbia University Medical Center.

No abstract available

Comment on

Use of traditional and complementary/alternative medicine (TCAM) in children with cancer in Guatemala.
Ladas EJ, Rivas S, Ndao D, Damoulakis D, Bao YY, Cheng B, Kelly KM, Antillon F. Ladas EJ, et al. Pediatr Blood Cancer. 2014 Apr;61(4):687-92. doi: 10.1002/pbc.24791. Epub 2013 Sep 21. Pediatr Blood Cancer. 2014. PMID: 24504792
The role and limitations of CAM use in children and adolescents with cancer: let's take a look beyond prevalence rates.
Meyer S, Schroeder N. Meyer S, et al. Pediatr Blood Cancer. 2014 Nov;61(11):2123. doi: 10.1002/pbc.25150. Epub 2014 Jul 25. Pediatr Blood Cancer. 2014. PMID: 25066784 No abstract available.